Trading Members of the Exchange are hereby informed that effective from Wednesday, July 26, 2023, the Equity Shares of ASARFI HOSPITAL LIMITED shall be listed and admitted to dealings on the Exchange in the list of 'MT' Group of Securities. Further in terms of SEBI circular No. CIR/MRD/DP/02/2012 dated January 20, 2012; the scrip will be in Trade-for-Trade segment for 10 trading days.
|
Name of the company
|
ASARFI HOSPITAL LIMITED
|
|
Registered Office:
|
Baramuri, Bishunpur Polytechnic, Dhanbad-828130 Jharkhand, India
Tel. No.: +91-96088 33708
Email: cs@asarfihospital.com
Website: www.asarfi.in
|
|
No. of Securities
|
1,96,77,300 Equity Shares of Rs.10/- each fully paid up
|
|
Distinctive Number range
|
1 To 19677300
|
|
Scrip ID on BOLT System
|
ASARFI
|
|
Abbreviated Name on BOLT System
|
ASARFI
|
|
Scrip Code
|
543943
|
|
ISIN No.
|
INE0DN001027
|
|
Market Lot
|
2000
|
|
Issue Price for the current Public issue
|
Rs. 52/- per share (Face Value of Rs. 10/- and premium of Rs. 42/-)
|
|
Date of Allotment in the public issue:
|
July 24, 2023
|
|
Pari Pasu
|
Yes
|
|
Financial Year
|
Mar-31
|
|
Lock in detail
|
As per Annexure I
|
|
Shareholding Pattern
|
As per Annexure II
|
a) Trading Members may note that as per the guidelines issued by SEBI dated 16th February, 2000, securities of the company will only be traded in Dematerialised form. Trades effected in this scrip will be in minimum market lot (i.e.2000equity shares) and the same shall be modified by the Exchange from time to time by giving prior market notice of atleast one month.
b) Further the trading members may please note that the above mentioned scrip will be a part of Special Pre-open Session (SPOS) on Wednesday, July 26, 2023. For further information on SPOS, the trading members are requested to refer to the Exchanges notice no. 20120216-29 dated February 16, 2012 on Enabling Special Pre-open Session for IPOs & Relisted Scrips.
c)The company has informed the Exchange that in respect of shares in demat form, necessary corporate action has been executed to have the lock-in period marked in the depositorys records.
d) The Market Maker to the issue as mentioned in the prospectus is given below:
|
Name Hem Finlease Private Limited
Correspondence Address 203, Jaipur Tower, M I Road, Jaipur, Rajasthan 302001, India.
Tel No. 0141-4051000
E-mail ib@hemsecurities.com
Website www.hemsecurities.com
Contact Person Mr. Ashok Soni
SEBI Registration No. INZ000167734
Market Maker Registration No. SMEMM0674109092020
|
e) The Registrar to the issue as mentioned in the prospectus is given below
|
CAMEO CORPORATE SERVICES LIMITED
Address: No.1 Club House Road Chennai-600002 Tamil Nadu, India.
Tel No.: +91-44-40020700
Email: priya@cameoindia.com
Investor Grievance Email: investor@cameoindia.com
Contact Person: K. Sreepriya Vice President & Company Secretary
Website: www.cameoindia.com
SEBI Registration Number: INR000003753
|
f) In case members require any clarifications on the subject matter of this notice, they may please contact any of the following:
|
a) At the company:
Seepika Gupta,
Company Secretary & Compliance Officer
|
Address:
Baramuri, Bishunpur Polytechnic, Dhanbad-828130 Jharkhand, India
Tel. No.: +91-96088 33708
Email: cs@asarfihospital.com
Website: www.asarfi.in
|
|
b) At the Exchange:
Mr. Raghavendra Bhat
Associate Manager
|
Tel.: (91) 022 2272 8915
|
Rupal Khandelwal
Deputy General Manager
Tuesday, July 25,2023 |